Stay updated on EMB-02 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the EMB-02 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the EMB-02 in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history shows a new revision (v3.4.2) added and the previous revision (v3.4.1) removed. This appears to be a minor update to the page's versioning with no changes to the study data or its status.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.4.1 was added to the Study Record Versions and the v3.4.0 entry was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history page now includes UI indicators for additions and deletions with green and red highlights, plus toggle options to Show/Hide glossary and a new Revision: v3.4.0 label replacing the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check61 days agoChange DetectedThe Record History shows a new entry Revision: v3.3.4 and removal of Revision: v3.3.3, a minor update to the page's revision history that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the history, and the footer was updated to remove 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to EMB-02 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMB-02 in Advanced Solid Tumors Clinical Trial page.